Summit Street Capital Management LLC Acquires 8,132 Shares of Humana Inc. (NYSE:HUM)

Summit Street Capital Management LLC grew its holdings in Humana Inc. (NYSE:HUM) by 33.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 32,683 shares of the insurance provider’s stock after purchasing an additional 8,132 shares during the period. Humana makes up about 2.9% of Summit Street Capital Management LLC’s holdings, making the stock its 14th biggest position. Summit Street Capital Management LLC’s holdings in Humana were worth $8,292,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Transcend Capital Advisors LLC raised its position in shares of Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock valued at $924,000 after purchasing an additional 2,914 shares during the period. Retirement Systems of Alabama raised its position in shares of Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after purchasing an additional 192,801 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock valued at $244,811,000 after purchasing an additional 65,735 shares during the period. Secure Asset Management LLC bought a new stake in shares of Humana in the fourth quarter valued at approximately $244,000. Finally, denkapparat Operations GmbH bought a new stake in shares of Humana in the fourth quarter valued at approximately $323,000. Institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on HUM. Raymond James raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $315.00 price objective for the company in a research note on Thursday, May 1st. Morgan Stanley reduced their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 12th. Guggenheim began coverage on shares of Humana in a research note on Wednesday, April 9th. They set a “buy” rating and a $326.00 price objective for the company. JPMorgan Chase & Co. reduced their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Seventeen investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $286.81.

Humana Price Performance

HUM stock opened at $237.42 on Friday. The stock has a market cap of $28.65 billion, a PE ratio of 23.86, a P/E/G ratio of 2.05 and a beta of 0.49. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a one year low of $212.45 and a one year high of $406.46. The firm has a 50 day simple moving average of $262.94 and a two-hundred day simple moving average of $269.49.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts’ consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The business’s quarterly revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the business posted $7.23 EPS. On average, analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.49%. Humana’s payout ratio is 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.